Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To investigate safety and tolerability of ascending doses of zanolimumab up to 20mg/kg in combination with CHOP chemotherapy in order to define a maximum tolerated dose (MTD) in subjects with CD4 positive non-cutaneous peripheral T-Cell Lymphoma with nodal involvement.
Critère d'inclusion
- CD4 positive non-cutaneous peripheral T-Cell Lymphoma with nodal involvement